News | August 10, 2022
Natco Pharma consolidated Q1FY23 PAT jumps to Rs. 320.4 Cr
The company has reported total income of Rs. 918.9 crores during the period ended June 30, 2022.
The company has reported total income of Rs. 918.9 crores during the period ended June 30, 2022.
Under the PMBJP, till 30.06.2022, 8742 PMBJKs have been opened across the country including Government Hospitals and Government premises.
India exported Bulk Drugs/Drug Intermediates worth Rs. 33,320 crore in financial year 2021-22.
He was appointed a Board member and the Chairman in 2012.
Steps afoot to make RRIH & RRIUM as a Centres of Excellence for Allergic Disorder and for Regimental Therapy respectively
The audit is part of the agency's inspection for three product applications filed and slated to be manufactured at this site.
Novartis India has reported total income of Rs. 147.44 crores during the period ended June 30, 2022.
The NTM-001 Phase I clinical study is expected to be completed by the end of 2022
India imported medical devices worth Rs. 63,200 crore in 2021-22, up 41% from Rs. 44,708 crore in 2020-21
The company was directed to submit a plan of compliance by July 15, 2022
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
